|
1
|
Iossifova Y, Bailey R, Wood J and Kreiss
K: Concurrent silicosis and pulmonary mycosis at death. Emerg
Infect Dis. 16:318–320. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hayes D Jr, Hayes KT, Hayes HC and Tobias
JD: Long-term survival after lung transplantation in patients with
silicosis and other occupational lung disease. Lung. 193:927–931.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Leung CC, Yu IT and Chen W: Silicosis.
Lancet. 379:2008–2018. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Song J, Rong Y, Cui X and Chen W: Advances
in research on the role of Gas 6/TAMin inflammation response and
silicosis induced by silica dusts. Zhonghua Lao Dong Wei Sheng Zhi
Ye Bing Za Zhi. 32:715–718. 2014.(In Chinese). PubMed/NCBI
|
|
5
|
Gera K, Pilaniya V and Shah A: Silicosis:
Progressive massive fibrosis with eggshell calcification. BMJ Case
Rep. 2014:bcr20142063762014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weng ZP, Zhang JJ, Liu WW, Chen J, Liu YM,
Yu W, Tang LJ, Chen JY, Fang M, Zhang C, et al: The experimental
study of suppressing silicosis fibrosis. Zhonghua Lao Dong Wei
Sheng Zhi Ye Bing Za Zhi. 29:740–745. 2011.(In Chinese). PubMed/NCBI
|
|
7
|
Beamer CA, Migliaccio CT, Jessop F,
Trapkus M, Yuan D and Holian A: Innate immune processes are
sufficient for driving silicosis in mice. J Leukoc Biol.
88:547–557. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Davis GS, Pfeiffer LM, Leslie KE and
Hemenway DR: Macrophage-lymphocyte cytokine interactions in
silicosis. Chest. 109(3): Suppl. 49S–50S. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Allison SJ: Fibrosis: Regulation of
fibrotic signalling by TGF-β receptor tyrosine phosphorylation. Nat
Rev Nephrol. 10:4842014. View Article : Google Scholar
|
|
10
|
Gao ZQ and Wang CH: Emodin and organ
fibrosis. Zhongguo Zhong Xi Yi Jie He Za Zhi. 25:1030–1032.
2005.(In Chinese). PubMed/NCBI
|
|
11
|
Chen XH, Sun RS, Hu JM, Mo ZY, Yang ZF,
Jin GY, Guan WD and Zhong NS: Inhibitory effect of emodin on
bleomycin-induced pulmonary fibrosis in mice. Clin Exp Pharmacol
Physiol. 36:146–153. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu C: Inhibition of mechanical
stress-induced hypertrophic scar inflammation by emodin. Mol Med
Rep. 11:4087–4092. 2015.PubMed/NCBI
|
|
13
|
Pooja T and Karunagaran D: Emodin
suppresses Wnt signaling in human colorectal cancer cells SW480 and
SW620. Eur J Pharmacol. 742:55–64. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang T, Zhong XG, Li YH, Jia X, Zhang SJ,
Gao YS, Liu M and Wu RH: Protective effect of emodin against airway
inflammation in the ovalbumin-induced mouse model. Chin J Integr
Med. 21:431–437. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang XZ, Wen D, Zhang M, Xie Q, Ma L,
Guan Y, Ren Y, Chen J and Hao CM: Sirt1 activation ameliorates
renal fibrosis by inhibiting the TGF-β/Smad3 pathway. J Cell
Biochem. 115:996–1005. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zerr P, Palumbo-Zerr K, Huang J, Tomcik M,
Sumova B, Distler O, Schett G and Distler JH: Sirt1 regulates
canonical TGF-β signalling to control fibroblast activation and
tissue fibrosis. Ann Rheum Dis. 75:226–233. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang T, Cui H, Ma N and Jiang Y:
Nicotinamide-mediated inhibition of SIRT1 deacetylase is associated
with the viability of cancer cells exposed to antitumor agents and
apoptosis. Oncol Lett. 6:600–604. 2013.PubMed/NCBI
|
|
18
|
Santos-Silva MA, Pires KM, Trajano ET,
Martins V, Nesi RT, Benjamin CF, Caetano MS, Sternberg C, Machado
MN, Zin WA, et al: Redox imbalance and pulmonary function in
bleomycin-induced fibrosis in C57BL/6, DBA/2 and BALB/c mice.
Toxicol Pathol. 40:731–741. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Subra JF, Renier G, Reboul P, Tollis F,
Boivinet R, Schwartz P and Chevailler A: Lymphopenia in
occupational pulmonary silicosis with or without autoimmune
disease. Clin Exp Immunol. 126:540–544. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
O'Connell M and Kennedy M: Progressive
massive fibrosis secondary to pulmonary silicosis appearance on
F-18 fluorodeoxyglucose PET/CT. Clin Nucl Med. 29:754–755. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kitaguchi Y, Fujimoto K, Hanaoka M, Honda
T, Hotta J and Hirayama J: Pulmonary function impairment in
patients with combined pulmonary fibrosis and emphysema with and
without airflow obstruction. Int J Chron Obstruct Pulmon Dis.
9:805–811. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Borthwick LA, Wynn TA and Fisher AJ:
Cytokine mediated tissue fibrosis. Biochim Biophys Acta.
1832:1049–1060. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tatler AL and Jenkins G: TGF-β activation
and lung fibrosis. Proc Am Thorac Soc. 9:130–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cutroneo KR: TGF-beta-induced fibrosis and
SMAD signaling: Oligo decoys as natural therapeutics for inhibition
of tissue fibrosis and scarring. Wound Repair Regen. 15:(Suppl 1).
S54–S60. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roberts AB, Tian F, Byfield SD, Stuelten
C, Ooshima A, Saika S and Flanders KC: Smad3 is key to
TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis,
tumor suppression and metastasis. Cytokine Growth Factor Rev.
17:19–27. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gauldie J, Bonniaud P, Sime P, Ask K and
Kolb M: TGF-beta, Smad3 and the process of progressive fibrosis.
Biochem Soc Trans. 35:661–664. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yu JL, Li JH, Chengz RG, Ma YM, Wang XJ
and Liu JC: Effect of matrine on transforming growth factor β1 and
hepatocyte growth factor in rat liver fibrosis model. Asian Pac J
Trop Med. 7:390–393. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen N, Geng Q, Zheng J, He S, Huo X and
Sun X: Suppression of the TGF-β/Smad signaling pathway and
inhibition of hepatic stellate cell proliferation play a role in
the hepatoprotective effects of curcumin against alcohol-induced
hepatic fibrosis. Int J Mol Med. 34:1110–1116. 2014.PubMed/NCBI
|
